Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
28.97
0.00 (0.00%)
At close: Aug 12, 2025
BIOVF Market Cap
BIOVF has a market cap or net worth of $9.88 billion as of August 15, 2025. Its market cap has increased by 13.78% in one year.
Market Cap
9.88B
Enterprise Value
11.11B
Revenue
2.84B
Ranking
n/a
PE Ratio
21.49
Stock Price
$28.97
Market Cap Chart
Since September 15, 2006, BIOVF's market cap has increased from 663.04M to 9.88B, an increase of 1,390.19%. That is a compound annual growth rate of 15.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 9.88B | 0.11% |
| Dec 30, 2024 | 9.87B | 9.77% |
| Dec 29, 2023 | 8.99B | 46.80% |
| Dec 30, 2022 | 6.12B | 1.41% |
| Dec 30, 2021 | 6.04B | 2.37% |
| Dec 30, 2020 | 5.90B | 21.03% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 598.01M |
| Elite Pharmaceuticals | 567.29M |
| American Oncology Network | 389.51M |
| Northwest Biotherapeutics | 351.78M |
| CytoDyn | 336.73M |